IP Library Granted Patent US 10,874,380
Granted Patent B2
US 10,874,380 · App. 15/915,409 · Granted Dec 29, 2020

Tissue removal system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,874,380
App. No.
15/915,409
Granted
Dec 29, 2020
Kind
B2
Abstract

A tissue removal device includes a housing, an outer tube having a distal portion configured for transcervical insertion into a uterus, an inner tube slidably disposed within the outer tube lumen, a vacuum generation chamber disposed within the housing, a movable piston slidably disposed in the vacuum generation chamber, a collection chamber, a manual actuator moveably coupled to the housing and operatively coupled to the piston, and proximal and distal one-way valves. The outer tube has an outer tube lumen, a tissue in-take opening proximate a distal end thereof, and a proximal end coupled to the housing. The inner tube has an inner tube lumen extending from an open inner tube distal end to an open inner tube proximal end, the open inner tube distal end comprising a cutting edge configured to sever intrauterine tissue extending through the tissue in-take opening in the outer tube.

Claims (28)

1. A method for resecting tissue from a uterus using a surgical device, the surgical device comprising a housing, a vacuum generation chamber located in the housing, a collection chamber, and a tube having a tube lumen, the method comprising:

transcervically introducing a distal portion of the surgical device into the uterus;

detaching uterine wall tissue from the uterus using the surgical device;

expanding the vacuum generation chamber, thereby generating vacuum in the vacuum generation chamber that causes the detached uterine wall tissue to be aspirated from the tube lumen into the vacuum generation chamber; and

after aspirating the detached uterine wall tissue from the the tube lumen into the vacuum generation chamber, expelling the detached uterine wall tissue from the vacuum generation chamber into the collection chamber.

2. The method of claim 1 , wherein expanding the vacuum generation chamber comprises actuating a manual actuator moveably coupled to the housing.

3. The method of claim 1 , wherein distension fluid passes from the tube lumen into the vacuum generation chamber before expanding the vacuum generation chamber.

4. The method of claim 3 , wherein distension fluid passes from the vacuum generation chamber into the collection chamber before expanding the vacuum generation chamber.

5. The method of claim 1 , wherein the detached uterine wall tissue is expelled from the vacuum generation chamber into the collection chamber after the vacuum generation chamber has been fully expanded.

6. The method of claim 5 , wherein the surgical device further comprises an outer tube having a sidewall opening, wherein the tube is an inner tube positioned within a lumen of the outer tube, and the lumen of the inner tube is an inner tube lumen in fluid communication with the sidewall opening in the outer tube, wherein generating vacuum in the vacuum generation chamber causes the uterine wall tissue to prolapse into the sidewall opening, and wherein detaching the uterine wall tissue comprises translating the inner tube relative to the outer tube to move the inner tube from a window open position to a window closed position, thereby severing the uterine wall tissue from the uterus.

7. The method of claim 6 , wherein the vacuum generation chamber is expanded while the inner tube is translated relative to the outer tube to move the inner tube from the window open position to the window closed position.

8. The method of claim 1 , wherein a proximal end of the vacuum generation chamber is distal to the collection chamber.

9. The method of claim 1 , wherein the vacuum generation chamber is expanded in a distal direction to generate the vacuum in the vacuum generation chamber.

10. The method of claim 1 , wherein the detached uterine wall tissue is expelled from the vacuum generation chamber into the collection chamber via a one-way valve located between the vacuum generation chamber and the collection chamber.

11. The method of claim 1 , wherein the uterine wall tissue is detached from the uterus with the surgical device while expanding the vacuum generation chamber in response to actuation of a manual actuator.

12. The method of claim 1 , wherein the vacuum generated in the vacuum generation chamber is prevented from being communicated to the collection chamber.

13. The method of claim 1 , wherein material in the collection chamber is prevented from entering the vacuum generation chamber while the vacuum is generated in the vacuum generation chamber.

14. The method of claim 13 , wherein a one-way valve prevents the material in the collection chamber from entering the vacuum generation chamber while the vacuum is generated in the vacuum generation chamber, and allows the detached uterine wall tissue to be expelled from the vacuum generation chamber into the collection chamber after the vacuum has been generated in the vacuum generation chamber.

15. The method of claim 1 , further comprising contracting the vacuum generation chamber, thereby increasing pressure in the vacuum generation chamber that causes the detached uterine wall tissue to be expelled from the vacuum generation chamber into the collection chamber.

16. The method of claim 15 , wherein the increased pressure in the vacuum generation chamber is prevented from being communicated to the tube lumen.

17. The method of claim 16 , wherein a one-way valve prevents material in the vacuum generation chamber from entering the tube lumen while contracting the vacuum generation chamber, and allows the detached uterine wall tissue to be aspirated from the tube lumen into the vacuum generation chamber while expanding the vacuum generation chamber.

18. The method of claim 1 ,

wherein material in the collection chamber is prevented from entering the vacuum generation chamber while the detached uterine wall tissue is aspirated from the tube lumen into the vacuum generation chamber; and

wherein material in the tube lumen is prevented from entering the vacuum generation chamber while the detached uterine wall tissue is expelled from the vacuum generation chamber into the collection chamber.

19. The method of claim 18 , further comprising contracting the vacuum generation chamber, thereby increasing pressure in the vacuum generation chamber to cause the detached uterine wall tissue to be expelled from the vacuum generation chamber into the collection chamber.

20. The method of claim 19 ,

wherein the tube lumen and the vacuum generation chamber are in fluid communication with each other via a one-way valve that, while the vacuum is generated in the vacuum generation chamber, allows the detached uterine wall tissue to be aspirated from the tube lumen into the vacuum generation chamber, and while the pressure is generated in the vacuum generation chamber, prevents material from the tube lumen from entering the vacuum generation chamber; and

wherein the vacuum generation chamber and the collection chamber are in fluid communication with each other via another one-way valve that, while the pressure is generated in the vacuum generation chamber, allows the detached uterine wall tissue to be expelled from the vacuum generation chamber into the collection chamber, and while the vacuum is generated in the vacuum generation chamber, prevents material from the collection chamber from entering the vacuum generation chamber.

Assignments (4)
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 12, 2021
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 057787/0526 →
SECURITY INTEREST Recorded Oct 19, 2018
From: HOLOGIC, INC.; GEN-PROBE INCORPORATED; CYNOSURE, INC.; FAXITRON BIOPTICS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047272/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2018
From: SULLIVAN, ROY H.; SCHENCK, JESSICA T.; MICHAELS, GEORGE C.
To: HOLOGIC, INC.
Reel/Frame 045144/0647 →